News

Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th

WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company…

1 year ago

BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023

Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023 North America Conference on Lung…

1 year ago

Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer

Dr. Gardner brings over 30 years of experience leading clinical development to support innovative oncology programs and translational research at…

1 year ago

Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics

DURHAM, N.C., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced…

1 year ago

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol's Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers of Cardiac…

1 year ago

Defence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Science

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

1 year ago

Berlin Cures takes next step in battle against Long COVID

Collaboration with Uniklinikum Erlangen as 5th German research centerBERLIN, GERMANY / ACCESSWIRE / October 10, 2023 / Berlin Cures, a…

1 year ago

Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone

GENEVA, SWITZERLAND / ACCESSWIRE / October 10, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…

1 year ago

IRLAB Signs Phase III Regulatory US Consultants to Support Preparation for Mesdopetam’s end-of-Phase 2 Meeting with the US FDA

GOTHENBURG, SWEDEN / ACCESSWIRE / October 10, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

1 year ago

iHealth to Offer Savings Up to 63% on Best Sellers During Amazon October Prime Big Deal Days

Featured Essential Healthcare Products Include Country's Preferred At-Home Covid TestSUNNYVALE, CA / ACCESSWIRE / October 10, 2023 / iHealth Labs,…

1 year ago